Literature DB >> 11733547

Caveolin-deficient mice: insights into caveolar function human disease.

B Razani1, M P Lisanti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11733547      PMCID： PMC201001          DOI： 10.1172/JCI14611

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  44 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Clathrin-mediated endocytosis: membrane factors pull the trigger.

Authors:  K Takei; V Haucke
Journal:  Trends Cell Biol       Date:  2001-09       Impact factor: 20.808

3.  Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.

Authors:  R C Betz; B G Schoser; D Kasper; K Ricker; A Ramírez; V Stein; T Torbergsen; Y A Lee; M M Nöthen; T F Wienker; J P Malin; P Propping; A Reis; W Mortier; T J Jentsch; M Vorgerd; C Kubisch
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

4.  Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo.

Authors:  W Schubert; P G Frank; B Razani; D S Park; C W Chow; M P Lisanti
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

5.  Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins.

Authors:  R Montesano; J Roth; A Robert; L Orci
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

6.  Caveolin-3 in muscular dystrophy.

Authors:  E M McNally; E de Sá Moreira; D J Duggan; C G Bönnemann; M P Lisanti; H G Lidov; M Vainzof; M R Passos-Bueno; E P Hoffman; M Zatz; L M Kunkel
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

7.  Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo.

Authors:  P E Scherer; R Y Lewis; D Volonte; J A Engelman; F Galbiati; J Couet; D S Kohtz; E van Donselaar; P Peters; M P Lisanti
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

8.  Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.

Authors:  F Galbiati; J A Engelman; D Volonte; X L Zhang; C Minetti; M Li; H Hou; B Kneitz; W Edelmann; M P Lisanti
Journal:  J Biol Chem       Date:  2001-03-19       Impact factor: 5.157

9.  Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease.

Authors:  M P Lisanti; P E Scherer; J Vidugiriene; Z Tang; A Hermanowski-Vosatka; Y H Tu; R F Cook; M Sargiacomo
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

10.  Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex.

Authors:  F Galbiati; D Volonte; C Minetti; J B Chu; M P Lisanti
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157
View more
  73 in total

1.  Transcriptional repression of Caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings.

Authors:  Ettickan Boopathi; Cristiano Mendes Gomes; Robert Goldfarb; Mary John; Vittala Gopal Srinivasan; Jaber Alanzi; S Bruce Malkowicz; Hasmeena Kathuria; Stephen A Zderic; Alan J Wein; Samuel Chacko
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Cholesterol, lipid rafts, and disease.

Authors:  Kai Simons; Robert Ehehalt
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 3.  The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology.

Authors:  Rennolds S Ostrom; Paul A Insel
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

4.  A new rat type I-like alveolar epithelial cell line R3/1: bleomycin effects on caveolin expression.

Authors:  Roland Koslowski; Kathrin Barth; Antje Augstein; Thomas Tschernig; Gerhard Bargsten; Michaela Aufderheide; Michael Kasper
Journal:  Histochem Cell Biol       Date:  2004-06-08       Impact factor: 4.304

Review 5.  Non-canonical roles for caveolin in regulation of membrane repair and mitochondria: implications for stress adaptation with age.

Authors:  Jan M Schilling; Hemal H Patel
Journal:  J Physiol       Date:  2015-10-14       Impact factor: 5.182

6.  Caveolin-1: a new locus for human lipodystrophy.

Authors:  Abhimanyu Garg; Anil K Agarwal
Journal:  J Clin Endocrinol Metab       Date:  2008-04       Impact factor: 5.958

7.  Antenatal inflammation reduces expression of caveolin-1 and influences multiple signaling pathways in preterm fetal lungs.

Authors:  Steffen Kunzmann; Jennifer J P Collins; Yang Yang; Stefan Uhlig; Suhar G Kallapur; Christian P Speer; Alan H Jobe; Boris W Kramer
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-11       Impact factor: 6.914

8.  The role of cell cholesterol and the cytoskeleton in the interaction between IK1 and maxi-K channels.

Authors:  Victor G Romanenko; Kurt S Roser; James E Melvin; Ted Begenisich
Journal:  Am J Physiol Cell Physiol       Date:  2009-01-28       Impact factor: 4.249

9.  Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells.

Authors:  Terence M Williams; Federica Sotgia; Hyangkyu Lee; Ghada Hassan; Dolores Di Vizio; Gloria Bonuccelli; Franco Capozza; Isabelle Mercier; Hallgeir Rui; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

10.  Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells.

Authors:  Beatriz G Gálvez; Salomón Matías-Román; María Yáñez-Mó; Miguel Vicente-Manzanares; Francisco Sánchez-Madrid; Alicia G Arroyo
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.